Announced Thu, 2 Jul · 18:35 IST
Board approves preferential share issue worth about 27.72 crore to non-promoters
Board & Shareholder Meetings View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve
Awaiting price reaction for this filing.
AI summary
Board of Asston Pharmaceuticals approved issuing up to 24,10,431 equity shares at Rs.115 each (face value Rs.10, premium of Rs.105) to non-promoter investors on a preferential basis, totaling about Rs.27.72 crore. Allottees include individuals and Vijaylaxmi Infra Projects Pvt Ltd. An Extraordinary General Meeting is scheduled for July 31, 2026 through video conferencing to seek shareholder approval for the issuance.
Likely market impact
Non-promoter preferential allotment of about 27.72 crore will dilute existing shareholders and may weigh on stock price until the EGM on July 31.